1. Home
  2. SVRE vs SNOA Comparison

SVRE vs SNOA Comparison

Compare SVRE & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SaverOne 2014 Ltd.

SVRE

SaverOne 2014 Ltd.

N/A

Current Price

$2.11

Market Cap

6.2M

Sector

N/A

ML Signal

N/A

Logo Sonoma Pharmaceuticals Inc.

SNOA

Sonoma Pharmaceuticals Inc.

N/A

Current Price

$1.26

Market Cap

6.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SVRE
SNOA
Founded
2014
1999
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2M
6.1M
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
SVRE
SNOA
Price
$2.11
$1.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 50.7K
49.9K
Earning Date
05-12-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 32.26
EPS
★ N/A
N/A
Revenue
N/A
★ $19,529,000.00
Revenue This Year
$1,793.31
$23.00
Revenue Next Year
N/A
$24.59
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 36.68
52 Week Low
$0.55
$0.85
52 Week High
$6.30
$4.60

Technical Indicators

Market Signals
Indicator
SVRE
SNOA
Relative Strength Index (RSI) 38.24 49.99
Support Level $2.02 $1.25
Resistance Level $3.98 $1.43
Average True Range (ATR) 0.26 0.05
MACD 0.00 -0.00
Stochastic Oscillator 6.20 57.11

Price Performance

Historical Comparison
SVRE
SNOA

About SVRE SaverOne 2014 Ltd.

Saverone 2014 Ltd is engaged in the design, development, and commercialization of transportation and safety solutions, designed to prevent car accidents based on its patented technology of detecting, analyzing, and locating cellular phone radio frequency, or RF signals. The company is developing two product lines: the first is an In-Cabin Driver Distraction Prevention Solution (known as SaverOne system), or DDPS; and the second is an Advanced Driver-Assistance System, or ADAS, product that detects vulnerable road users, or VRUs, and provides a warning to the vehicle regarding potential collision. Geographically, Saverone generates maximum revenue from Europe and the rest from Israel.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: